November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Pashtoon Kasi: 150 papers on PubMed
Nov 10, 2024, 19:08

Pashtoon Kasi: 150 papers on PubMed

Pashtoon Kasi, Medical Director of GI Medical Oncology at City of Hope, Orange County, shared on X:

“150 papers now on PubMed.

Great for this paper as the personal milestone. Building upon research/clinical focus:

– Developing novel therapies for our patients with colorectal and other cancers

– ctDNA and biomarkers.”

Pashtoon Kasi: 150 papers on PubMed

Neoadjuvant immunotherapy for dMMR and pMMR colorectal cancers: therapeutic strategies and putative biomarkers of response

Authors: Christopher J. M. Williams, Allyson M. Peddle, Pashtoon M. Kasi, Jenny F. Seligmann, Campbell S. Roxburgh, Gary W. Middleton and Sabine Tejpar

Pashtoon Kasi: 150 papers on PubMed

More posts featuring Pashtoon Kasi on oncodaily.com

Further Reading:

Pashtoon Kasi has started a new position as Medical Director GI Medical Oncology at City of Hope Orange County

Oncoinfluencers to Follow on Social Media: Dr. Pashtoon Kasi

Oncologist Near Me: Pashtoon Kasi – Pioneering Cancer Specialist

Dr. Pashtoon Kasi is the Medical Director of GI Medical Oncology at City of Hope, Orange County. Previously, Dr. Kasi served as an Associate Professor of Medicine in the Division of Hematology and Oncology at the University of Iowa, following positions as an Assistant Professor of Medicine and Oncology at both the University of Iowa and Mayo Clinic. He also served as the Director of Colon Cancer Research and Director of Precision Medicine Research for Liquid Biopsies at Weill Cornell Medicine.

His research primarily focuses on “liquid biopsies,” particularly circulating tumor DNA (ctDNA) and circulating tumor cells (CTCs). Dr. Kasi is also recognized as an author and editor of several significant books, including “Research: What, Why, and How: A Treatise from Researchers to Researchers” and “Impact of Circulating Tumor DNA (ctDNA) in Patients with Gastrointestinal Malignancies.” His scholarly contributions extend to over 100 publications in esteemed peer-reviewed journals. He also received the Yvonne Award 2024 by OncoDaily in the “challenging the status quo” category.